<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
MKM Partners analyst Bill Kirk on Tuesday upgraded shares of Aurora Cannabis ACB, +7.31% to neutral from sell and increased his fair value price for the stock from C$6 to C$7 after the Canadian cannabis company reported a narrower than expected EBITDA loss of C$13.9 million, compared to the consensus estimate for a loss of C$16.9 million. Kirk said Aurora continues to face a struggling recreational-use business, and despite a consistent medical business, sees volatility in the international market.
...read full article on Market Watch
